Sophia Genetics Sa2024财年实现净利润-62.49百万美元，同比增加20.88%

市场透视2025-03-09

3月9日，Sophia Genetics Sa（SOPH.US）公布财报，公告显示公司2024财年净利润为-62.49百万美元，同比增加20.88%；其中营业收入为65.17百万美元，同比增加4.49%，每股基本收益为-0.95美元。从资产负债表来看，Sophia Genetics Sa（SOPH.US）总负债59.92百万美元，其中短期债务2.19百万美元，资产负债比为0.03，流动比率为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2518842817?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-09 00:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2518842817","market":"us","top_or_hot":-1,"title":"Sophia Genetics Sa2024财年实现净利润-62.49百万美元，同比增加20.88%","media":"市场透视","content":"<div>\n<p>3月9日，Sophia Genetics Sa（SOPH.US）公布财报，公告显示公司2024财年净利润为-62.49百万美元，同比增加20.88%；其中营业收入为65.17百万美元，同比增加4.49%，每股基本收益为-0.95美元。从资产负债表来看，Sophia Genetics Sa（SOPH.US）总负债59.92百万美元，其中短期债务2.19百万美元，资产负债比为0.03，流动比率为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000325abef9954&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sophia Genetics Sa2024财年实现净利润-62.49百万美元，同比增加20.88%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSophia Genetics Sa2024财年实现净利润-62.49百万美元，同比增加20.88%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-09 00:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000325abef9954&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>3月9日，Sophia Genetics Sa（SOPH.US）公布财报，公告显示公司2024财年净利润为-62.49百万美元，同比增加20.88%；其中营业收入为65.17百万美元，同比增加4.49%，每股基本收益为-0.95美元。从资产负债表来看，Sophia Genetics Sa（SOPH.US）总负债59.92百万美元，其中短期债务2.19百万美元，资产负债比为0.03，流动比率为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000325abef9954&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SOPH","symbol_name":"SOPHiA GENETICS SA","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000325abef9954&s=b","article_id":"2518842817","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000325abef9954&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2518842817","pubTimestamp":1741449702,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"3月9日，Sophia Genetics Sa公布财报，公告显示公司2024财年净利润为-62.49百万美元，同比增加20.88%；其中营业收入为65.17百万美元，同比增加4.49%，每股基本收益为-0.95美元。机构评级：截至2025年3月9日，当前有5家机构对Sophia Genetics Sa目标价做出预测，其中目标均价为6.80美元，其中最低目标价为5.00美元，最高目标价为11.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"SOPH":"SOPHiA GENETICS SA"},"translate_title":"Sophia Genetics Sa achieved net profit of-US $62.49 million in fiscal year 2024, a year-on-year increase of 20.88%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SOPH":0.6},"content_text":"3月9日，Sophia Genetics Sa（SOPH.US）公布财报，公告显示公司2024财年净利润为-62.49百万美元，同比增加20.88%；其中营业收入为65.17百万美元，同比增加4.49%，每股基本收益为-0.95美元。从资产负债表来看，Sophia Genetics Sa（SOPH.US）总负债59.92百万美元，其中短期债务2.19百万美元，资产负债比为0.03，流动比率为3.71。机构评级：截至2025年3月9日，当前有5家机构对Sophia Genetics Sa目标价做出预测，其中目标均价为6.80美元，其中最低目标价为5.00美元，最高目标价为11.00美元。公司简介：Sophia Genetics SA是一家医疗保健技术公司，致力于将数据驱动医学作为护理和生命科学研究的标准。公司建立了一个基于云的SaaS平台，能够分析数据并从复杂的多模态数据集和不同的诊断模式中生成见解。该公司在瑞士总部以外的三个国家有实体存在:法国、美国和巴西。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2518842817","isCrawlerRequest":true}